Selection of Active ScFv to G-Protein-Coupled Receptor CCR5 Using Surface Antigen-Mimicking Peptides
- 4 September 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 43 (39) , 12575-12584
- https://doi.org/10.1021/bi0492152
Abstract
This study describes the use of cyclic peptides for use in the selection of single-chain (ScFv) antibodies specific for the HIV-1 coreceptor CCR5, a representative G-protein-coupled receptor (GPCR). A tandem ligation strategy was developed for preparing biotinylated cyclic peptides, first through an orthogonal end-to-end ligation and then a chemoselective ligation with functionalized biotin. Cyclic peptides mimicking the extracellular loops of CCR5 and their unconstrained counterparts were then used for solution-phase selection of ScFv antibodies from a phage display antibody library. Antibodies reactive with CCR5 on cells were detected using a homogeneous high throughput assay. Of 19 isolated ScFv antibodies that bound to CCR5+ cells, three inhibited CCR5-mediated but not CXCR4-mediated HIV infection. Only ScFvs selected by binding to cyclic constrained peptides exhibited inhibitory activity. Our results demonstrate that surface-antigen mimetics of a GPCR are effective tools for selecting active, site-specific ScFv antibodies that hold promise as immunological reagents and therapeutics.Keywords
This publication has 15 references indexed in Scilit:
- Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 EntryJournal of Virology, 2003
- Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140Journal of Virology, 2001
- Generation and Characterization of a Recombinant Human CCR5-specific AntibodyJournal of Biological Chemistry, 2000
- CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In VitroThe Journal of Immunology, 2000
- Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaquesEuropean Journal of Immunology, 1999
- HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 geneThe Lancet, 1998
- Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32Journal of Biological Chemistry, 1997
- Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected IndividualsThe Journal of Experimental Medicine, 1997
- Macromolecular assemblage in the design of a synthetic AIDS vaccine.Proceedings of the National Academy of Sciences, 1992
- Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.Proceedings of the National Academy of Sciences, 1988